Achyut Healthcare Quarterly Results for Trading Insights
In 2026, Achyut Healthcare (ACHYUT) reported revenue ₹12 Cr and net profit ₹0 Cr. Analyse ACHYUT FII DII holdings to track promoter, FII and institutional holdings.
ACHYUT Quarterly Results — Revenue, Profit & EPS Highlights
Achyut Healthcare latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Achyut Healthcare stock price NSE.
- Revenue of ₹12 Cr in March 2026 (+0.0% vs March 2026, +200.0% vs March 2025)
- Operating Margin of 1.0% in March 2026 (+0.0pp vs March 2026)
- Earnings Per Share of ₹0.01 in March 2026 (+0.0% vs March 2026)
Achyut Healthcare Quarterly Results — Revenue, EBITDA, Net Profit & EPS
ACHYUT quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | 2026 | March 2026 | March 2025 | March 2024 | March 2023 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 12 | 12 | 4 | 7 | 3 | - | - |
| Net Profit (₹ Cr) | 0 | 0 | 1 | 1 | 0 | - | - |
| EBITDA (₹ Cr) | 1 | 0 | 1 | 1 | 0 | - | - |
| EPS (₹) | 0.00 | 0.01 | 0.02 | 0.34 | 0.25 | - | - |
| Operating Margin (%) | 2.0% | 1.0% | -7.0% | 0.0% | -10.0% | - | - |
ACHYUT Share Price Trend — 1-Year Movement Across Quarterly Results
Achyut Healthcare 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check ACHYUT market value to track the company's total market size over time.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
ACHYUT vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Achyut Healthcare latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹463,071.60 Cr | 1902.4 | 15,018 | 2,710 | -5.6% | - | 18.0% | 168.4 |
|
Divis Laboratories
Mar 2026 |
₹225,157.18 Cr | 8597.0 | 2,986 | 751 | -5.0% | - | 25.2% | 303.7 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹188,719.51 Cr | 4896.5 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 425.4 |
|
Cipla
Mar 2026 |
₹115,699.61 Cr | 1432.2 | 6,612 | 543 | -9.3% | - | 8.2% | 208.5 |
|
Zydus Life Science
Mar 2026 |
₹113,855.38 Cr | 1120.0 | 7,569 | 1,341 | -4.3% | - | 17.7% | 88.5 |
All amounts in ₹ Crores